Multiple Sclerosis Clinical Trials
Multiple Sclerosis clinical trials study new therapies, devices, and diagnostic tools for multiple Sclerosis and related neurological symptoms. Corterve gathers actively recruiting Multiple Sclerosis studies from ClinicalTrials.gov so you can filter them by where you live and whether you may qualify. Neurology trials often include cognitive, imaging, or biomarker assessments. This page is informational only and is not medical advice; discuss participation with your neurologist or physician.
Recruiting Multiple Sclerosis studies
- The Effect of Remotely Delivered Pilates on Physical , and Psychological Outcomes in Individuals With Multiple SclerosisNCT07504120NAUniversity of Illinois at ChicagoMultiple SclerosisChicago, Illinois
- Comprehensive Multimodal Analysis of Neuroimmunological Diseases of the Central Nervous SystemNCT00794352National Institute of Allergy and Infectious Diseases (NIAID)Central Nervous System DiseaseBethesda, Maryland
- Entire-body PET Scans for Multiple SclerosisNCT04390009EARLY_PHASE1Brain Health AllianceMultiple SclerosisLadera Ranch, California
- Targeting Residual Activity By Precision, Biomarker-Guided Combination Therapies of Multiple Sclerosis (TRAP-MS)NCT03109288PHASE1, PHASE2National Institute of Allergy and Infectious Diseases (NIAID)Multiple SclerosisBethesda, Maryland
- Investigating the Utility of Demyelination Tracer [18F]3F4AP in Controls and Multiple Sclerosis SubjectsNCT04699747PHASE1Massachusetts General HospitalMultiple SclerosisBoston, Massachusetts
- A Study of Orelabrutinib in Patients With Secondary Progressive Multiple SclerosisNCT07299019PHASE3Zenas BioPharma (USA), LLCSecondary Progressive Multiple SclerosisPhoenix, Arizona
- Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVONCT03816345PHASE1National Cancer Institute (NCI)Autoimmune DiseaseBirmingham, Alabama
- A Study of Orelabrutinib in Patients With Primary Progressive Multiple SclerosisNCT07067463PHASE3Zenas BioPharma (USA), LLCMultiple Sclerosis (MS) Primary ProgressivePheonix, Arizona
- Effect of Corticosteroids on Inflammation at the Edge of Acute Multiple Sclerosis PlaquesNCT02784210PHASE2National Institute of Neurological Disorders and Stroke (NINDS)Multiple SclerosisBethesda, Maryland
- A Study of the MIND Diet for Persons With Multiple SclerosisNCT06992115NAIcahn School of Medicine at Mount SinaiMultiple SclerosisNew York, New York
- A Study to Evaluate the Efficacy, Safety and Tolerability of BMS-986368 in Participants With Multiple Sclerosis SpasticityNCT06782490PHASE2CelgeneMultiple Sclerosis SpasticityBirmingham, Alabama
- A Study of Ocrelizumab Administered Subcutaneously in Participants With Multiple Sclerosis Who Switch From an Approved Anti-CD20 TherapyNCT07609719PHASE4Genentech, Inc.Multiple SclerosisScottsdale, Arizona
Multiple Sclerosis trials by state
Multiple Sclerosis trials by metro
Frequently asked questions
- How do I find recruiting Multiple Sclerosis clinical trials?
- Browse the actively recruiting Multiple Sclerosis studies listed on this page, or take an assessment to see trials you may qualify for based on your profile.
- Are Multiple Sclerosis clinical trials free to join?
- Costs, travel support, and any payment for taking part vary by study. Ask the study team what is covered before you decide to join.
- Who can take part in a Multiple Sclerosis clinical trial?
- Each study has its own eligibility criteria (for example age, disease stage, and prior treatments). This page is general information and not medical advice; discuss any specific trial with your healthcare provider to confirm whether it is appropriate for you.